Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes

NCT00212290 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT00212290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00212290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2002
Completion date
December 31, 2006
Enrollment
140 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, type 2 diabetes mellitus